The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ventizolve 1.26 mg nasal spray, solution in single-dose container

DNE Pharma ASPA22993/001/001

Main Information

Trade NameVentizolve 1.26 mg nasal spray, solution in single-dose container
Active SubstancesNaloxone
Dosage FormNasal spray, solution in single-dose container
Licence HolderDNE Pharma AS
Licence NumberPA22993/001/001

Group Information

ATC CodeV03AB15 naloxone


License statusAuthorised
Licence Issued22/02/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back